Sharp Shalini - Insider Non-Derivative Transactions at Mirati Therapeutics, Inc. (MRTX) - (SEC)

Updated on December 12, 2024.

According to recent SEC insider information filed on Jan 23, 2024, Sharp Shalini's relationship to Mirati Therapeutics, Inc. (MRTX) is Director, and currently has 12,060 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other MRTX insiders.

Data Source: SEC.
Sharp Shalini - Insider Non-Derivative Transactions of MRTX Common Stock
Sharp Shalini - Insider Non-Derivative Transactions at MRTX
Items per page:
0 of 0
Date Transaction No. of Shares Price Per Share Shares Owned After Transactions
Jan 24, 2024 Disposition -- (Common Stock) 6808 0 0
Jan 24, 2024 Disposition -- (Common Stock) 5252 0 6808
Jan 24, 2024 Disposition -- (Common Stock) 4162 0 12060
Dec 30, 2023 Acquisition -- (Common Stock) 6808 58.75 16222
Jan 21, 2023 Acquisition -- (Common Stock) 4444 0 9414